Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.
Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions.
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020 12; 2(12):1401-1412.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Azaserine
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Enzyme Inhibitors
Gene Expression Regulation, Neoplastic
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
Hexosamines
Humans
Lung Neoplasms
Metabolic Networks and Pathways
Metabolomics
Mice
Mutation
Proto-Oncogene Proteins p21(ras)
Survival Analysis
Tumor Stem Cell Assay
authors with profiles
Brandon Faubert